Zura Bio Limited/$ZURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Ticker
$ZURA
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
30
ISIN
KYG9TY5A1016
Website
Zura Bio Limited Metrics
BasicAdvanced
$65M
-
-$0.72
0.04
-
Price and volume
Market cap
$65M
Beta
0.04
52-week high
$1.68
52-week low
$0.97
Average daily volume
746K
Financial strength
Current ratio
8.14
Quick ratio
8.087
Profitability
Management effectiveness
Return on assets (TTM)
-31.40%
Return on equity (TTM)
-55.05%
Valuation
Price to book
0.52
Price to tangible book (TTM)
0.52
Price to free cash flow (TTM)
-2.653
Free cash flow yield (TTM)
-37.70%
Free cash flow per share (TTM)
-39.59%
Growth
Earnings per share change (TTM)
-47.67%
Zura Bio Limited News
AllArticlesVideos
Zura Bio to Present at the Jefferies Global Healthcare Conference
Business Wire·1 month ago
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa
Business Wire·1 month ago
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zura Bio Limited stock?
Zura Bio Limited (ZURA) has a market cap of $65M as of June 30, 2025.
What is the P/E ratio for Zura Bio Limited stock?
The price to earnings (P/E) ratio for Zura Bio Limited (ZURA) stock is 0 as of June 30, 2025.
Does Zura Bio Limited stock pay dividends?
No, Zura Bio Limited (ZURA) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Zura Bio Limited dividend payment date?
Zura Bio Limited (ZURA) stock does not pay dividends to its shareholders.
What is the beta indicator for Zura Bio Limited?
Zura Bio Limited (ZURA) has a beta rating of 0.04. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.